INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 49 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $300 | +1.0% | 3,000 | 0.0% | 0.01% | -6.7% |
Q1 2023 | $297 | +1.0% | 3,000 | 0.0% | 0.02% | -6.2% |
Q4 2022 | $294 | -100.0% | 3,000 | -76.9% | 0.02% | -77.1% |
Q3 2022 | $1,251,000 | +0.2% | 13,000 | 0.0% | 0.07% | +2.9% |
Q2 2022 | $1,248,000 | +5.1% | 13,000 | 0.0% | 0.07% | +25.9% |
Q1 2022 | $1,188,000 | -2.9% | 13,000 | 0.0% | 0.05% | +1.9% |
Q4 2021 | $1,224,000 | +5.0% | 13,000 | 0.0% | 0.05% | -3.6% |
Q3 2021 | $1,166,000 | +0.1% | 13,000 | 0.0% | 0.06% | 0.0% |
Q2 2021 | $1,165,000 | +10.1% | 13,000 | 0.0% | 0.06% | -6.8% |
Q1 2021 | $1,058,000 | +5.6% | 13,000 | 0.0% | 0.06% | -33.0% |
Q4 2020 | $1,002,000 | +315.8% | 13,000 | +333.3% | 0.09% | +282.6% |
Q3 2020 | $241,000 | +6.6% | 3,000 | 0.0% | 0.02% | +9.5% |
Q2 2020 | $226,000 | -5.8% | 3,000 | 0.0% | 0.02% | -27.6% |
Q1 2020 | $240,000 | -20.5% | 3,000 | 0.0% | 0.03% | +7.4% |
Q4 2019 | $302,000 | +17.1% | 3,000 | 0.0% | 0.03% | +8.0% |
Q3 2019 | $258,000 | -3.4% | 3,000 | 0.0% | 0.02% | -7.4% |
Q2 2019 | $267,000 | -10.1% | 3,000 | 0.0% | 0.03% | -15.6% |
Q1 2019 | $297,000 | +7.6% | 3,000 | 0.0% | 0.03% | -8.6% |
Q4 2018 | $276,000 | -8.9% | 3,000 | 0.0% | 0.04% | +2.9% |
Q3 2018 | $303,000 | +15.2% | 3,000 | 0.0% | 0.03% | +3.0% |
Q2 2018 | $263,000 | – | 3,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 5,324,000 | $4,995,000 | 3.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $53,020,000 | 2.12% |
DLD Asset Management, LP | 32,500,000 | $30,048,000 | 2.06% |
Castle Creek Arbitrage, LLC | 4,504,000 | $4,161,000 | 1.43% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 10,000,000 | $9,372,000 | 0.62% |
Graham Capital Management, L.P. | 14,636,000 | $13,509,000 | 0.60% |
OAKTREE CAPITAL MANAGEMENT LP | 64,452,000 | $59,704,000 | 0.54% |
Context Capital Management, LLC | 1,000,000 | $926,000 | 0.52% |
ADVENT CAPITAL MANAGEMENT /DE/ | 23,118,000 | $21,341,000 | 0.52% |
WOLVERINE ASSET MANAGEMENT LLC | 18,583,000 | $17,322,000 | 0.21% |